ES2364314T8 - Detección y predicción de preeclampsia. - Google Patents

Detección y predicción de preeclampsia. Download PDF

Info

Publication number
ES2364314T8
ES2364314T8 ES07700392T ES07700392T ES2364314T8 ES 2364314 T8 ES2364314 T8 ES 2364314T8 ES 07700392 T ES07700392 T ES 07700392T ES 07700392 T ES07700392 T ES 07700392T ES 2364314 T8 ES2364314 T8 ES 2364314T8
Authority
ES
Spain
Prior art keywords
preeclampsy
preaching
detection
technology described
predicting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07700392T
Other languages
English (en)
Other versions
ES2364314T3 (es
Inventor
Lucilla Poston
Andrew Shennan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revvity Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Application granted granted Critical
Publication of ES2364314T3 publication Critical patent/ES2364314T3/es
Publication of ES2364314T8 publication Critical patent/ES2364314T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Mold Materials And Core Materials (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Holo Graphy (AREA)
ES07700392T 2006-01-17 2007-01-17 Detección y predicción de preeclampsia. Active ES2364314T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
GB0600916 2006-01-17

Publications (2)

Publication Number Publication Date
ES2364314T3 ES2364314T3 (es) 2011-08-31
ES2364314T8 true ES2364314T8 (es) 2011-09-22

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07700392T Active ES2364314T3 (es) 2006-01-17 2007-01-17 Detección y predicción de preeclampsia.

Country Status (10)

Country Link
US (1) US7638287B2 (es)
EP (1) EP1974220B1 (es)
JP (1) JP2009524014A (es)
AT (1) ATE504002T1 (es)
AU (1) AU2007206756B2 (es)
CA (1) CA2602681C (es)
DE (1) DE602007013524D1 (es)
ES (1) ES2364314T3 (es)
GB (1) GB0600916D0 (es)
WO (1) WO2007083099A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA022609B1 (ru) 2007-02-12 2016-02-29 А1М Фарма Аб Применение свободного фетального гемоглобина в качестве маркера преэклампсии
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
WO2009094665A1 (en) * 2008-01-25 2009-07-30 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
US20110294227A1 (en) * 2008-11-20 2011-12-01 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
HRP20150802T1 (xx) * 2010-03-24 2015-11-06 Preelumina Diagnostics Ab Hbf i a1m kao markeri za rano otkrivanje preeklampsije
AU2012351504C1 (en) * 2011-12-15 2018-04-26 Mycartis N.V. Biomarkers and parameters for preeclampsia
US20150157276A1 (en) * 2012-04-24 2015-06-11 Siemens Healthcare Diagnostics Inc. Pre-eclampsia screening methods
EP2954324B1 (en) * 2013-02-08 2019-07-31 University of Iowa Research Foundation Method using copeptin to predict onset of preeclampsia
US10119978B2 (en) 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
PL3189336T3 (pl) 2014-09-02 2019-07-31 Wallac Oy Sposób określania ryzyka stanu przedrzucawkowego
FR3037657B1 (fr) * 2015-06-22 2017-06-23 Univ Rouen Centre Hospitalier Methode de diagnostic des troubles causes par l'alcoolisation foetale
WO2019099998A1 (en) * 2017-11-17 2019-05-23 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECLAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR TESTS
WO2022173786A1 (en) * 2021-02-10 2022-08-18 Mirvie, Inc. Methods and systems for conducting pregnancy-related clinical trials
FR3157091A1 (fr) * 2023-12-26 2025-06-27 Universite De Montpellier Prédiction du comportement biomécanique de la paroi artérielle à travers l’analyse temporelle du signal oscillométrique au cours de la mesure de pression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028006A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
ES2556164T3 (es) * 2003-09-23 2016-01-13 The General Hospital Corporation Cribado de la preeclampsia
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Also Published As

Publication number Publication date
AU2007206756A1 (en) 2007-07-26
CA2602681C (en) 2017-03-14
CA2602681A1 (en) 2007-07-26
US7638287B2 (en) 2009-12-29
EP1974220A1 (en) 2008-10-01
EP1974220B1 (en) 2011-03-30
ES2364314T3 (es) 2011-08-31
GB0600916D0 (en) 2006-02-22
JP2009524014A (ja) 2009-06-25
DE602007013524D1 (de) 2011-05-12
HK1119244A1 (en) 2009-02-27
AU2007206756B2 (en) 2011-06-16
ATE504002T1 (de) 2011-04-15
WO2007083099A1 (en) 2007-07-26
US20070178530A1 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
ES2364314T8 (es) Detección y predicción de preeclampsia.
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2009058902A3 (en) Methods and devices for analyte detection
MX2020004617A (es) Prediccion de riesgo de evento cardiovascular y usos del mismo.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2114241A4 (en) METHOD AND SYSTEM FOR PROVIDING ANALYTE MONITORING
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
WO2010129934A3 (en) Methods and compositions for diagnosis of thyroid conditions
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
BR112013006240A2 (pt) processo para detecção, diferenciação e quantificação de populações de células-t através da tecnologia quantitativa pcr (rt-qpcr) de transcrição reversa, em tempo real
MX2007011510A (es) Metodo y aparato para proveer informacion de tiempo de viaje y congestion a usuarios.
WO2014065889A3 (en) Multiplexed method for diagnosing classical hodgkin lymphoma
BRPI1013896A2 (pt) Célula de levedura, e, métodos para produzir um composto isoprenóide e para detectar em uma amostra biológica a presença ou ausência de uma célula microbiana geneticamente.
WO2012170206A3 (en) Color-producing diagnostic systems, reagents and methods
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
TW200745551A (en) Device and methods for detecting and quantifying one or more target agents
WO2010075360A3 (en) Methods for detection of sepsis
AU2011285694A8 (en) Detection of degradation products of canine NT-proBNP
WO2008150010A1 (ja) γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2009129173A3 (en) Methods, antibodies and kits for detecting cerebrospinal fluid in a sample
WO2013090386A3 (en) Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample
WO2012025637A9 (en) An agglutination assay method and device
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
NZ601648A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure